Discover how the avian erythroblastosis virus p75 protein reveals fundamental mechanisms of leukemia development and potential therapeutic targets.
Explore the groundbreaking phase I study of IMGN632, a novel CD123-targeting antibody-drug conjugate showing promise for relapsed/refractory acute myeloid leukemia.